CV6 Therapeutics, (NI) Ltd.
Declan Doherty is a Senior Scientist at CV6 Therapeutics, (NI) Ltd. with a background in mesenchymal stem cells for treating respiratory diseases. Previously, Declan worked as a Postdoctoral Research Fellow at Queen's University Belfast focusing on mesenchymal stem cell therapy for respiratory and cancer-related conditions. Before that, Declan was a Research Project Manager at Almac Diagnostics Ltd and a Research Associate at both the University of Ulster and Fusion Antibodies Ltd. Declan holds a PhD in Nuclear Receptors/Molecular Biology/Gene Expression and has additional qualifications in teaching and research.
This person is not in any teams
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is developing value-based, first-in-class medications that are scalable to address global unmet medical needs in the oncology and inflammatory disease markets. For further questions or information on investment or career opportunities please contact: information@cv6t.com